HCA Healthcare, Inc. $HCA Shares Sold by TIAA Trust National Association

TIAA Trust National Association lessened its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 18.1% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 993 shares of the company’s stock after selling 220 shares during the quarter. TIAA Trust National Association’s holdings in HCA Healthcare were worth $380,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Brighton Jones LLC acquired a new position in shares of HCA Healthcare during the fourth quarter worth $1,021,000. D.A. Davidson & CO. lifted its holdings in HCA Healthcare by 34.2% in the 1st quarter. D.A. Davidson & CO. now owns 3,656 shares of the company’s stock worth $1,263,000 after buying an additional 931 shares in the last quarter. OneDigital Investment Advisors LLC increased its position in shares of HCA Healthcare by 8.9% during the first quarter. OneDigital Investment Advisors LLC now owns 1,304 shares of the company’s stock worth $451,000 after acquiring an additional 107 shares during the last quarter. Capital Investment Advisory Services LLC acquired a new stake in HCA Healthcare during the 1st quarter valued at approximately $200,000. Finally, Concurrent Investment Advisors LLC boosted its stake in shares of HCA Healthcare by 5.2% during the 1st quarter. Concurrent Investment Advisors LLC now owns 2,142 shares of the company’s stock valued at $740,000 after buying an additional 106 shares during the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

Insider Activity at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 3,836 shares of the business’s stock in a transaction that occurred on Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the sale, the executive vice president owned 31,503 shares in the company, valued at $13,194,716.52. The trade was a 10.85% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Michael R. Mcalevey sold 3,892 shares of HCA Healthcare stock in a transaction that occurred on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the transaction, the executive vice president owned 3,487 shares in the company, valued at approximately $1,652,105.73. The trade was a 52.74% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Company insiders own 1.30% of the company’s stock.

Analyst Ratings Changes

HCA has been the topic of a number of research analyst reports. Mizuho increased their price objective on shares of HCA Healthcare from $475.00 to $505.00 and gave the company an “outperform” rating in a research note on Monday, October 27th. Robert W. Baird upped their price objective on HCA Healthcare from $380.00 to $423.00 and gave the company a “neutral” rating in a research note on Thursday, August 14th. Truist Financial raised their target price on shares of HCA Healthcare from $460.00 to $495.00 and gave the stock a “buy” rating in a report on Monday, October 27th. Morgan Stanley set a $425.00 price target on HCA Healthcare in a research report on Monday, October 27th. Finally, Jefferies Financial Group increased their target price on HCA Healthcare from $485.00 to $525.00 and gave the stock a “buy” rating in a research report on Tuesday, October 28th. One research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and ten have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $473.53.

HCA Healthcare Trading Up 0.3%

NYSE:HCA opened at $472.97 on Thursday. HCA Healthcare, Inc. has a twelve month low of $289.98 and a twelve month high of $478.19. The firm has a market cap of $107.93 billion, a price-to-earnings ratio of 18.28, a price-to-earnings-growth ratio of 1.38 and a beta of 1.41. The company has a 50-day moving average of $425.01 and a 200-day moving average of $389.68.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Friday, October 24th. The company reported $6.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.64 by $1.32. The firm had revenue of $19.16 billion for the quarter, compared to analyst estimates of $18.55 billion. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The firm’s quarterly revenue was up 9.6% compared to the same quarter last year. During the same quarter in the previous year, the business posted $4.90 earnings per share. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. On average, research analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 29th. Shareholders of record on Monday, December 15th will be issued a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a yield of 0.6%. The ex-dividend date is Monday, December 15th. HCA Healthcare’s payout ratio is presently 11.13%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.